Products Categories
| CAS No.: | 128270-60-0 |
|---|---|
| Name: | Bivalirudin |
| Article Data: | 11 |
| Molecular Structure: | |
|
|
|
| Formula: | C98H138N24O33 |
| Molecular Weight: | 2180.31 |
| Synonyms: | L-Leucine,D-phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-a-aspartyl-L-phenylalanyl-L-a-glutamyl-L-a-glutamyl-L-isoleucyl-L-prolyl-L-a-glutamyl-L-a-glutamyl-L-tyrosyl-;126:PN: WO2004076484 PAGE: 31 claimed protein;Angiomax;BG 8967;Hirulog;Hirulog 1;Bivalirudin Trifluoroacetate; |
| Density: | 1.52 g/cm3 |
| Appearance: | White powder |
| PSA: | 901.57000 |
| LogP: | 0.54320 |
- 144851-82-1METHYL2-AMINO-3-FLUOROBENZOATE
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 173606-50-3BOC-10-AMINODECANOIC ACID
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 128270-60-0
bivalirudin
| Conditions | Yield |
|---|---|
| With water; trifluoroacetic acid; 1-dodecylthiol at 20℃; for 1h; Reagent/catalyst; | 110 g |
- 21691-53-2
L-leucine tert-butyl ester
- 29022-11-5
N-(fluoren-9-ylmethoxycarbonyl)glycine
- 112883-29-1, 92954-90-0
N-Fmoc-Tyr-OH
- 18942-49-9
Boc-D-Phe-OH
- 71989-31-6
Fmoc-Pro-OH
- 71989-18-9
Fmoc-Glu(OtBu)-OH
- 71989-23-6
Fmoc-Ile-OH
- 132388-59-1
L-Asn(Trt)
- 128270-60-0
bivalirudin
| Conditions | Yield |
|---|---|
| Stage #1: L-leucine tert-butyl ester; N-Fmoc-Tyr-OH With benzotriazol-1-ol; diisopropyl-carbodiimide In 1-methyl-pyrrolidin-2-one; dichloromethane at 0 - 30℃; Stage #2: With piperidine In 1-methyl-pyrrolidin-2-one Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; Fmoc-Arg(Pbf)-OH; H-Asp-(tBu); Boc-D-Phe-OH; Fmoc-Pro-OH; Fmoc-Glu(OtBu)-OH; Fmoc-Ile-OH; L-Asn(Trt) Further stages; |
- Boc-D-Phe-Pro-Arg(Pbf)-Pro-Gly-Gly-Gly-Gly-Asn(Trt)-Gly-Asp(OtBu)-Phe-Glu(OtBu)-Glu(OtBu)-Ile-Pro-Glu(OtBu)-Glu(OtBu)-Tyr(tBu)-Leu-O(benzyl(3,4,5-tridihydrophtyloxy))
Boc-D-Phe-Pro-Arg(Pbf)-Pro-Gly-Gly-Gly-Gly-Asn(Trt)-Gly-Asp(OtBu)-Phe-Glu(OtBu)-Glu(OtBu)-Ile-Pro-Glu(OtBu)-Glu(OtBu)-Tyr(tBu)-Leu-O(benzyl(3,4,5-tridihydrophtyloxy))
- 128270-60-0
bivalirudin
| Conditions | Yield |
|---|---|
| With chlorotriisopropylsilane; trifluoroacetic acid In water at 20℃; for 3h; Cooling with ice; |
- 29022-11-5
N-(fluoren-9-ylmethoxycarbonyl)glycine
- 35661-60-0
Fmoc-Leu-OH
- 71989-31-6
Fmoc-Pro-OH
- 35661-40-6
N-Fmoc L-Phe
- 71989-14-5
Fmoc-(tBu)Asp-OH
- 71989-18-9
Fmoc-Glu(OtBu)-OH
- 71989-23-6
Fmoc-Ile-OH
- 71989-38-3
Fmoc-Tyr(tBu)-OH
- 132388-59-1
L-Asn(Trt)
- 128270-60-0
bivalirudin
| Conditions | Yield |
|---|---|
| Stage #1: Fmoc-Leu-OH With N-ethyl-N,N-diisopropylamine at 90℃; for 0.0833333h; Automated synthesizer; Stage #2: With pyrrolidine at 95℃; for 0.0138889h; Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; Fmoc-Pro-OH; N-Fmoc L-Phe; Fmoc-(tBu)Asp-OH; Fmoc-Glu(OtBu)-OH; Fmoc-Ile-OH; Fmoc-Tyr(tBu)-OH; L-Asn(Trt); Fmoc-D-Phe-OH; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine Further stages; |
- HCl*H-D-Phe-Pro-Arg(Pbf)-Pro-Gly-Gly-Gly-Gly-Asn(Trt)-Gly-Asp(OtBu)-Phe-Glu(OtBu)-Glu(OtBu)-Ile-Pro-Glu(OtBu)-Glu(OtBu)-Tyr(tBu)-Leu-OKb, Kb=2,4-didocosyloxybenzyl
HCl*H-D-Phe-Pro-Arg(Pbf)-Pro-Gly-Gly-Gly-Gly-Asn(Trt)-Gly-Asp(OtBu)-Phe-Glu(OtBu)-Glu(OtBu)-Ile-Pro-Glu(OtBu)-Glu(OtBu)-Tyr(tBu)-Leu-OKb, Kb=2,4-didocosyloxybenzyl
- 128270-60-0
bivalirudin
| Conditions | Yield |
|---|---|
| With chlorotriisopropylsilane; water; trifluoroacetic acid at 20℃; for 3h; |
- 143491-57-0Emtricitabine
- 61-76-7Benzenemethanol, 3-hydroxy-α-[(methylamino)methyl]-,hydrochloride (1:1), (aR)-
- 28721-07-5Oxcarbazepine
- 616-47-71-Methylimidazole
- 88-17-52-Aminobenzotrifluoride
- 100-09-4Benzoic acid,4-methoxy-
- 64872-77-1Butoconazole nitrate
- 70-55-3p-Toluenesulfonamide
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Specification
1. Introduction of Bivalirudin
Bivalirudin is one kind of white powder or off-white powder. The IUPAC Name of it is (15S,21S,24S,27S,30S)-15-(2-Amino-2-oxoethyl)-1-[(2S)-1-{(2S)-2-[({(2S)-1-[(2R)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl} carbonyl)amino]-5-carbamimidamidopentanoyl}pyrrolidin-2-yl]-24-benzyl-30-({(2S,3S)-1-[(2S)-2 -{[(2S)-4-carboxy-1-{[(2S)-4-carboxy-1-{[(2S)-1-{[(1S)-1-carboxy-3-methylbutyl]amino}-3 -(4-hydroxyphenyl)-1-oxopropan-2-yl]amino}-1-oxobutan-2-yl]amino}-1-oxobutan-2-yl]carbamoyl}pyrroli\ndin -1-yl]-3-methyl-1-oxopentan-2-yl}carbamoyl)-27-(2-carboxyethyl)-21-(carboxymethyl)-1,4,7,10,13,16,19,22, 25,28-decaoxo-2,5,8,11,14,17,20,23,26,29-decaazatritriacontan-33-oic acid.
It is belongs to Peptide. The Classification Code of Bivalirudin is Anticoagulant; Anticoagulants; Antithrombins; Antithrombotic; Enzyme Inhibitors; Hematologic Agents; Protease Inhibitors; Serine Proteinase Inhibitors. Bivalirudin is readily soluble in water and freely filtered at the glomerulus.
2. Properties of Bivalirudin
Physical properties about Bivalirudin are:
(1)Density: 1.52 g/cm3; (2)Freely Rotating Bonds: 68; (3)Polar Surface Area: 901.57 Å2; (4)Index of Refraction: 1.674; (5)Molar Refractivity: 537.76 cm3; (6)Molar Volume: 1431.3 cm3; (7)Surface Tension: 69.5 dyne/cm.
3. Structure Descriptors of Bivalirudin
(1)InChI: InChI=1S/C98H138N24O33/c1-5-52(4)82(96(153)122-39-15-23-70(122)92(149)114-60(30-34-79(134)135)85(142)111-59(29-33-78(132)133)86(143)116-64(43-55-24-26-56(123)27-25-55)89(146)118-67(97(154)155)40-51(2)3)119-87(144)61(31-35-80(136)137)112-84(141)58(28-32-77(130)131)113-88(145)63(42-54-18-10-7-11-19-54)117-90(147)66(45-81(138)139)110-76(129)50-107-83(140)65(44-71(100)124)109-75(128)49-106-73(126)47-104-72(125)46-105-74(127)48-108-91(148)68-21-13-38-121(68)95(152)62(20-12-36-103-98(101)102)115-93(150)69-22-14-37-120(69)94(151)57(99)41-53-16-8-6-9-17-53/h6-11,16-19,24-27,51-52,57-70,82,123H,5,12-15,20-23,28-50,99H2,1-4H3,(H2,100,124)(H,104,125)(H,105,127)(H,106,126)(H,107,140)(H,108,148)(H,109,128)(H,110,129)(H,111,142)(H,112,141)(H,113,145)(H,114,149)(H,115,150)(H,116,143)(H,117,147)(H,118,146)(H,119,144)(H,130,131)(H,132,133)(H,134,135)(H,136,137)(H,138,139)(H,154,155)(H4,101,102,103)/t52-,57+,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,82-/m0/s1
(2)InChIKey: InChIKey=OIRCOABEOLEUMC-GEJPAHFPSA-N
(3)Smiles: C([C@H]1N(CCC1)C([C@@H](Cc1ccccc1)N)=O)(=O)N[C@H](C(N1[C@H](C(=O)NCC(=O)NCC(NCC(=O)NCC(=O)N[C@H](C(NCC(=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@H](C(N[C@H](C(N[C@@H](Cc2ccc(O)cc2)C(N[C@@H](CC(C)C)C(=O)O)=O)=O)CCC(O)=O)=O)CCC(O)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CCC(O)=O)=O)Cc2ccccc2)=O)CC(O)=O)=O)CC(=O)N)=O)CCC1)=O)CCCNC(N)=N
4. Uses of Bivalirudin
Bivalirudin (CAS NO.128270-60-0) is a specific and reversible direct thrombin inhibitor (DTI). Chemically, it is a synthetic congener of the naturally occurring drug hirudin (found in the saliva of the medicinal leech Hirudo medicinalis). It is a DTI which overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is used as alternative medicine to unfractionated heparin and platelet glycoprotein IIb / IIIa antagonist. Bivalirudin is an anticoagulant.
Bivalirudin is intended for IV use only and is supplied as a sterile, lyophilized product in single-use, glass vials. After reconstitution, each vial delivers 250 mg of bivalirudin. Bivalirudin clinical studies demonstrated consistent positive outcomes in patients with stable angina, unstable angina (UA), non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) undergoing PCI in 7 major randomized trials.
-
Premium Related Products
